Loading...
Investor Info 2019-07-03T15:11:30+00:00
INVESTOR PRESENTATIONS
FACT SHEETS
REGULATION A+ OFFERING CIRCULAR
  • Emerald Health Pharmaceuticals updates its offering disclosure in accordance with securities regulations relating to its Regulation A + offering and recently filed its Final Offering Circular, as Supplemented, with the Securities and Exchange Commission, on June 27, 2019 [click here to access the Final Offering Circular link].  Please click here to view our dedicated investment website where you can find details on the investment process and additional information on the company.
SIGN UP FOR OUR NEWSLETTER